Home > Insider Trading > Filing (0000899243-22-015325)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1693011	Inozyme Pharma Inc.	INZY	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1253886	G Patrick Enright	2740 Sand Hill Rd 2Nd Floor Menlo Park CA 94025	No	No	Yes	No
1431159	Juliet Bakker Tammenoms	2740 Sand Hill Road, 2Nd Floor Menlo Park CA 94025	No	No	Yes	No
1674099	Longitude Venture Partners Iii, L.p.	2740 Sand Hill Rd 2Nd Floor Menlo Park CA 94025	No	No	Yes	No
1713663	Longitude Capital Partners Iii, Llc	2740 Sand Hill Road Second Floor Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-04-19	1,355,000	$3.69	4,174,379	No	4	P	Indirect	By Longitude Venture Partners III, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Longitude Venture Partners III, L.P.

Footnotes

These shares are held by Longitude Venture Partners III, L.P. ("LVP III"). Longitude Capital Partners III, LLC ("LCP III") is the general partner of LVP III and may be deemed to have voting and dispositive power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and dispositive power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.